MedTrace Logo

Bedside Ultrasound Predicts Progression of Severity of Disease in Dengue Fever

NCT03632486 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2019-10-10

No results posted yet for this study

Summary

The purpose of this study is determine the ability of bedside ultrasound performed in the Emergency Department and Outpatient Department can predict the severity of disease during a Dengue Fever outbreak in children, in Siem Reap, Cambodia. Our hypothesis is that the presence of gallbladder wall thickening, pulmonary edema/effusions, ascites, pericardial effusion in children correlates with progression to more severe disease.

Conditions

Interventions

OTHER

Bedside Ultrasound

Patients enrolled in this study will undergo bedside ultrasound during their initial presentation to the emergency department. Ultrasound imaging protocols include the following: * FAST Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) sub-xyphoid 2)right upper quadrant (with right thorax) 3)left upper quadrant (with left thorax) and 4) suprapubic * Right Upper Quadrant Exam - Standard images will be obtained using the abdominal transducer. Images include the following: 1) Long axis of the gallbladder 2) Transverse axis of the gallbladder fundus 3) Transverse axis of the gallbladder body and 4) Transverse axis of the gallbladder neck. * Lung ultrasound to assess for pleural effusions and sonographic b lines.

Sponsors & Collaborators

  • Angkor Hospital for Children

    collaborator OTHER

  • Timothy Gleeson

    lead OTHER

Principal Investigators

  • Romolo Gaspari, MD PhD · UMass Worcester

Eligibility

Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-13
Primary Completion
2019-10-01
Completion
2019-10-01

Countries

  • Cambodia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03632486 on ClinicalTrials.gov